Form 4: DocuSign Director Sells Shares Under Pre-Arranged Plan

DocuSign Director Teresa Briggs sold 364 shares of common stock for $79.39 per share on September 11, 2025, as part of a Rule 10b5-1 trading plan.

Summary

• Teresa Briggs, a Director of DocuSign, Inc. (DOCU), reported a sale of common stock.
• The transaction involved the disposition of 364 shares of DocuSign common stock.
• The shares were sold at a price of $79.39 per share.
• The transaction occurred on September 11, 2025.
• Following this transaction, Teresa Briggs beneficially owns 9,170 shares of DocuSign common stock directly.
• The sale was executed pursuant to a Rule 10b5-1 plan, indicating a pre-scheduled transaction.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider stock sale under a 10b5-1 plan, which is a neutral event from a company performance perspective. It does not indicate any new positive or negative developments for DocuSign.

Positives

• The transaction was conducted under a Rule 10b5-1 plan, which demonstrates a pre-planned sale and mitigates concerns about opportunistic insider trading.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, though the small volume (364 shares) is unlikely to have a significant impact.

Risks

• No specific risks to the company's operations or financial health are disclosed in this Form 4 filing.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This routine insider transaction by a director is specific to DocuSign and does not provide broader insights into industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: A minor, pre-planned insider sale is unlikely to have a significant impact on shareholder sentiment or the stock price.

Key Dates

Recommendation

The filing details a routine insider stock sale by a director under a Rule 10b5-1 plan. This type of transaction is pre-scheduled and does not typically reflect new information about the company's operational performance or future prospects. Therefore, it does not provide a basis for changing an investment recommendation based solely on this disclosure.

Keywords

DocuSign, DOCU, Teresa Briggs, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Director